These findings indicated therefore that B7-H3-CXCR2 CAR T cells exhibited greater persistence and anti-tumor activity than B7-H3 CAR T cells and indicated that CXCR2 signaling contributed multiple beneficial effects on overall CAR T cell function, not limited to only enhanced recruitment. This evidence concerns the gene CD276 and neoplasm.